Lanean...
Advances in the use of PARP inhibitor therapy for breast cancer
Poly-ADP-ribose polymerase 1 (PARP-1) and PARP-2 are DNA damage sensors that are most active during S-phase of the cell cycle and that have wider-reaching roles in DNA repair than originally described. BRCA1 and BRCA2 (Breast Cancer) proteins are involved in homologous recombination repair (HRR), wh...
Gorde:
| Argitaratua izan da: | Drugs Context |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioExcel Publishing Ltd
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6089618/ https://ncbi.nlm.nih.gov/pubmed/30116283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212540 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|